Who Paid My Doc
1st replapse after len-containing regimen
Research payments
$159,985
Through program year 2020, $159,985 in research payments was reported against 1st replapse after len-containing regimen, across 18 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $159,985 | 18 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Habte Yimer Tyler, TX Named on 2 payments
- Moshe Levy Dallas, TX Named on 2 payments
- Rami Haddad Oak Lawn, IL Named on 2 payments
- Edward Faber Cincinnati, OH Named on 2 payments
- Jason Melear Austin, TX Named on 2 payments
- Amanda Gillespie-Twardy Roanoke, VA Named on 1 payment
- Terri Parker New Haven, CT Named on 1 payment
- Robert Rifkin Denver, CO Named on 1 payment
- David Siegel Hackensack, NJ Named on 1 payment
- Timothy Larson Rochester, MN Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.